[go: up one dir, main page]

DK3074384T3 - Amidderivater til gpr119-agonist - Google Patents

Amidderivater til gpr119-agonist Download PDF

Info

Publication number
DK3074384T3
DK3074384T3 DK14866648.0T DK14866648T DK3074384T3 DK 3074384 T3 DK3074384 T3 DK 3074384T3 DK 14866648 T DK14866648 T DK 14866648T DK 3074384 T3 DK3074384 T3 DK 3074384T3
Authority
DK
Denmark
Prior art keywords
amidderivates
gpr119 agonist
gpr119
agonist
Prior art date
Application number
DK14866648.0T
Other languages
English (en)
Inventor
Yun Tae Kim
Changsik Lee
Daekyu Choi
Moosung Ko
Younghue Han
Soyoung Kim
Jaeki Min
Dohoon Kim
Original Assignee
Chong Kun Dang Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Pharmaceutical Corp filed Critical Chong Kun Dang Pharmaceutical Corp
Application granted granted Critical
Publication of DK3074384T3 publication Critical patent/DK3074384T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK14866648.0T 2013-11-26 2014-11-25 Amidderivater til gpr119-agonist DK3074384T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130144601 2013-11-26
PCT/KR2014/011356 WO2015080446A1 (en) 2013-11-26 2014-11-25 Amide derivatives for gpr119 agonist

Publications (1)

Publication Number Publication Date
DK3074384T3 true DK3074384T3 (da) 2019-07-15

Family

ID=53199342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14866648.0T DK3074384T3 (da) 2013-11-26 2014-11-25 Amidderivater til gpr119-agonist

Country Status (20)

Country Link
US (1) US9776987B2 (da)
EP (1) EP3074384B1 (da)
JP (1) JP6182269B2 (da)
KR (1) KR101700906B1 (da)
CN (2) CN110028494A (da)
AU (1) AU2014354488B2 (da)
BR (1) BR112016011999A2 (da)
CA (1) CA2930850C (da)
DK (1) DK3074384T3 (da)
ES (1) ES2731823T3 (da)
HR (1) HRP20191246T1 (da)
HU (1) HUE045926T2 (da)
MX (1) MX366297B (da)
NZ (1) NZ720304A (da)
PH (1) PH12016500980A1 (da)
PL (1) PL3074384T3 (da)
PT (1) PT3074384T (da)
RU (1) RU2642429C2 (da)
TR (1) TR201908098T4 (da)
WO (1) WO2015080446A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7745559B2 (ja) 2020-02-28 2025-09-29 キャリーオペ,インク. Gpr40アゴニスト
BR112022023359A2 (pt) 2020-05-19 2023-04-18 Kallyope Inc Ativadores de ampk
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ,インク. Ampkアクチベーター

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
EP1167326B2 (en) 2000-06-26 2007-11-14 Saudi Basic Industries Corporation Dimerization of isobutene
ATE384036T1 (de) 2000-07-13 2008-02-15 Merck Patent Gmbh Chirale verbindungen i
AU2002212282A1 (en) 2000-10-20 2002-05-06 Merck Patent G.M.B.H Chiral binaphthol derivatives
DE102004037515A1 (de) 2003-08-22 2005-03-17 Merck Patent Gmbh Verfahren zur Herstellung von Aldehyden
WO2008025800A1 (en) 2006-08-30 2008-03-06 Biovitrum Ab (Publ) Pyrimidine compounds for treating gpr119 related disorders
BRPI0719941A2 (pt) 2006-12-06 2014-04-22 Smithkline Beecham Corp Composto, uso de um composto, método para o tratamento de distúrbios ou condições metabólicos, composição farmacêutica, e, processo para a preparação de uma composição farmacêutica
EA015129B1 (ru) 2007-01-04 2011-06-30 Прозидион Лимитед Пиперидиновые агонисты gpcr
CN101754962B (zh) 2007-07-19 2013-12-25 赛马拜制药公司 作为rup3或gpr119受体的激动剂治疗糖尿病和代谢性病症的n-氮杂环状经取代吡咯、吡唑、咪唑、三唑和四唑衍生物
CA2697551C (en) 2007-09-20 2013-03-12 Irm Llc Piperidine derivatives as modulators of gpr119 activity
WO2009106561A1 (en) * 2008-02-27 2009-09-03 Biovitrum Ab (Publ) Pyrazine compounds for treating gpr119 related disorders
WO2009106565A1 (en) 2008-02-27 2009-09-03 Biovitrum Ab (Publ) Agonists of gpr119
MX2011000392A (es) * 2008-07-11 2011-03-01 Irm Llc 4-fenoxi-metil-piperidinas como moduladoras de la actividad de gpr119.
WO2010048149A2 (en) 2008-10-20 2010-04-29 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
AR077638A1 (es) 2009-07-15 2011-09-14 Lilly Co Eli Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
WO2011127051A1 (en) * 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2011145718A1 (ja) 2010-05-21 2011-11-24 田辺三菱製薬株式会社 新規ピロロ[2,3-d]ピリミジン化合物
TW201202230A (en) * 2010-05-24 2012-01-16 Mitsubishi Tanabe Pharma Corp Novel quinazoline compound
CN102432598A (zh) * 2010-09-29 2012-05-02 江苏恒瑞医药股份有限公司 三环化合物、其制备方法及其在医药上的应用
AU2011333472A1 (en) 2010-11-26 2013-06-06 Lupin Limited Bicyclic GPR119 modulators
WO2012077655A1 (ja) 2010-12-07 2012-06-14 塩野義製薬株式会社 Gpr119アゴニスト活性を有するスピロ誘導体
JP2014159376A (ja) 2011-06-17 2014-09-04 Taisho Pharmaceutical Co Ltd アザスピロアルカン化合物
NZ630488A (en) 2012-06-12 2016-07-29 Chong Kun Dang Pharm Corp Piperidine derivatives for gpr119 agonist
EP2862763B1 (en) * 2012-06-13 2015-12-09 Nissan Motor Co., Ltd. Driving force controller for vehicle

Also Published As

Publication number Publication date
JP2016538296A (ja) 2016-12-08
PH12016500980B1 (en) 2016-06-20
HRP20191246T1 (hr) 2019-12-27
US20170129875A1 (en) 2017-05-11
RU2016125492A (ru) 2018-01-09
EP3074384B1 (en) 2019-05-22
TR201908098T4 (tr) 2019-06-21
CN110028494A (zh) 2019-07-19
HUE045926T2 (hu) 2020-01-28
JP6182269B2 (ja) 2017-08-16
RU2642429C2 (ru) 2018-01-25
NZ720304A (en) 2017-08-25
PT3074384T (pt) 2019-07-10
CN105873916A (zh) 2016-08-17
ES2731823T3 (es) 2019-11-19
AU2014354488A1 (en) 2016-06-09
CA2930850C (en) 2017-05-16
MX366297B (es) 2019-07-04
CN105873916B (zh) 2019-08-27
US9776987B2 (en) 2017-10-03
CA2930850A1 (en) 2015-06-04
MX2016006904A (es) 2016-10-28
EP3074384A1 (en) 2016-10-05
BR112016011999A2 (pt) 2017-08-08
EP3074384A4 (en) 2017-04-19
PH12016500980A1 (en) 2016-06-20
KR101700906B1 (ko) 2017-01-31
AU2014354488B2 (en) 2017-08-24
WO2015080446A1 (en) 2015-06-04
PL3074384T3 (pl) 2019-09-30
KR20150060573A (ko) 2015-06-03

Similar Documents

Publication Publication Date Title
DK3572105T3 (da) Injektionsindretning til terapeutisk middel
LT3057586T (lt) Bromodomeno inhibitoriai
AR095266A1 (es) Inhibidores de bromodominios tetraciclicos
EP2969007A4 (en) HISTONE DEMETHYLASE INHIBITORS
LT3060041T (lt) Prostaciklino junginiai
EP2948458A4 (en) BTK INHIBITORS
DK2970336T3 (da) Tetrahydropyrrolothiazinforbindelser
IL244825B (en) Injection device
EP2948431A4 (en) BTK INHIBITORS
DK2968225T3 (da) Neosaxitoxinkombinationsformuleringer til forlænget lokalanæstesi
FI20136201A7 (fi) Laitteen tuki
DK3079743T3 (da) Anordning
DK2956071T3 (da) Sæt til perifer nerveblokering
HUE037417T2 (hu) Szubsztituált imidazopiridazinok
BR112015022372A2 (pt) dispositivo
DK2999544T3 (da) Substansfragmenterende indretning
IL240904A0 (en) Azetidinyloxyphenylpyrrolidine compounds
DK2837678T3 (da) Fremgangsmåde til forbedret afsmeltning
DK2951552T3 (da) Opfangningsanordning til engangsbrug
HRP20180618T1 (hr) Spojevi fluorfenilpirazola
DK2964206T3 (da) Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar
DK3074384T3 (da) Amidderivater til gpr119-agonist
DK2882041T3 (da) Lederkontaktpunkt
DE112013007428A5 (de) Komponententräger
DE112013006679T8 (de) Schlaufenziehervorrichtung